VP-16-213 - A PHASE-II STUDY OF NON-SMALL CELL LUNG-CANCER (NSCLC)

被引：0
|
作者：
ITRI, LM [1 ]
GRALLA, RJ [1 ]
KELSEN, DP [1 ]
CHAPMAN, RA [1 ]
GOLBEY, RB [1 ]
KAUFMAN, RJ [1 ]
YOUNG, CW [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF VP-16-213 IN NON-SMALL-CELL LUNG-CANCER
    ITRI, LM
    GRALLA, RJ
    CHAPMAN, RA
    KELSEN, DP
    CASPER, ES
    GOLBEY, RB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 45 - 47
  • [2] PHASE-II TRIAL OF VP16-213 IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    CHAPMAN, R
    ITRI, L
    GRALLA, R
    KELSEN, D
    CASPER, E
    GOLBEY, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 205 - 207
  • [3] PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER
    MATSUI, Y
    OSHIMA, S
    KADO, M
    NAKAYAMA, M
    SHIMOKATA, K
    SAKAI, S
    ITO, F
    CHIKATA, E
    HARA, K
    KANDA, T
    SHIMA, K
    TAKENAKA, S
    HOKAMA, S
    GENGA, K
    CANCER, 1987, 60 (12) : 2882 - 2885
  • [4] PHASE-II STUDY INDUCTION CHEMOTHERAPY IN SMALL CELL LUNG-CANCER (CISPLATINUM, CYCLOPHOSFAMIDE, VP-16-213)
    MEINESZ, AF
    POSTMUS, PE
    SLEYFER, DT
    SLUITER, HJ
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 47 - 47
  • [5] CIS-DICHLORODIAMMINEPLATINUM (II) AND VP-16-213 COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    GOLDHIRSCH, A
    JOSS, RA
    CAVALLI, F
    SONNTAG, RW
    BRUNNER, KW
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03): : 205 - 208
  • [6] PHASE-II CLINICAL-STUDY OF CIS-DICHLORODIAMMINEPLATINUM (CDDP) AND VP-16-213 (VP16) IN COMBINATION FOR PATIENTS (PTS) WITH EXTENSIVE NON-SMALL CELL LUNG-CANCER (E-NSCLC)
    DHINGRA, HM
    VALDIVIESO, M
    UMSAWASDI, T
    SPITZER, G
    MURPHY, WK
    CHIUTEN, DF
    BOOSER, DJ
    MOUNTAIN, CF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 200 - 200
  • [7] CIS-PLATINUM AND VP-16-213 (ETOPOSIDE) COMBINATION CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG-CANCER - A PHASE-II CLINICAL-TRIAL
    KLIPPSTEIN, T
    GRAUBNER, M
    BERDEL, WE
    MENDE, S
    GROPP, C
    DIEHL, V
    MITROU, PS
    ONKOLOGIE, 1983, 6 (06): : 306 - 311
  • [8] CISPLATINUM, VINDESINE AND VP 16-213 IN THE TREATMENT OF INOPERABLE NON-SMALL CELL LUNG-CANCER - A PHASE-II TRIAL
    GATZEMEIER, U
    ZSCHABER, R
    HOSSFELD, DK
    RADENBACH, D
    ONKOLOGIE, 1984, 7 (05): : 308 - 315
  • [9] A PHASE-II STUDY OF ORAL VP-16-213 IN NON-SEMINOMATOUS TESTICULAR CANCER
    CAVALLI, F
    KLEPP, O
    RENARD, J
    ROHRT, M
    ALBERTO, P
    EUROPEAN JOURNAL OF CANCER, 1981, 17 (02) : 245 - 249
  • [10] PHASE-II STUDY OF VP-16-213 (ETOPOSIDE) IN METASTATIC TRANSITIONAL CELL UROTHELIAL CANCER
    PONDER, BAJ
    OLIVER, RTD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (01) : 64 - 65
12345